A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1997
10/16/1997	WO1997038012A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997	WO1997038004A1 Gene family associated with neurosensory defects
10/16/1997	WO1997038002A1 Extracellular/epidermal growth factor-like protein
10/16/1997	WO1997037998A2 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037678A1 Drug for the treatment of tumours
10/16/1997	WO1997037668A1 Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation
10/16/1997	WO1997037662A1 5-ANDROSTENE 3β,17α DIOL AS AN INHIBITOR OF TUMOR GROWTH
10/16/1997	WO1997037645A1 Correction of genetic defects using chemical chaperones
10/16/1997	WO1997037631A2 Chemotherapeutic veterinary drug containing oxytetracycline, sulfadimidine and neomycin
10/16/1997	WO1997032588A3 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
10/16/1997	WO1997028826A3 Contraceptive release systems with antibacterial and/or antiviral effect
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2251603A1 Gene family associated with neurosensory defects
10/16/1997	CA2250868A1 Human cachexia associated protein
10/16/1997	CA2250839A1 Drug for the treatment of tumours
10/16/1997	CA2250780A1 Correction of genetic defects using chemical chaperones
10/16/1997	CA2250722A1 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997	CA2250268A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997	CA2249213A1 Extracellular/epidermal growth factor-like protein
10/15/1997	EP0800829A1 Antitumor agent potentiator comprising il-6 antagonist
10/15/1997	EP0800815A2 Use of at least one lypoxygenase inhibitor and at least one cyclo-oxygenase inhibitor to alter hair growth
10/15/1997	EP0800581A1 POLYMERASE $g(d) MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS
10/15/1997	EP0800536A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
10/15/1997	EP0800532A1 Improved cyclic crf agonists
10/15/1997	EP0800530A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
10/15/1997	EP0800399A1 Combined therapeutical treatment of hyperproliferative diseases
10/15/1997	EP0800394A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals
10/15/1997	EP0800388A1 Compounds for veterinary and medicinal applications
10/15/1997	EP0772396A4 Method of regulating immune function
10/14/1997	US5677427 Chimeric antibody for detection and therapy of infectious and inflammatory lesions
10/14/1997	US5677344 Administering a sulfonyl urea or quinine
10/14/1997	US5677340 Method of using gluconic acid or gluconolactone for treating wrinkles
10/14/1997	US5677339 Method of using mandelic acid for treating wrinkles
10/14/1997	US5677330 Therapy hypoxia, hypothermia, ischemic, wounds, ulcers, tissue transplants, sespis
10/14/1997	US5677312 Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation
10/14/1997	US5677290 Therapeutic use of adenosine compounds as surgical anesthetics
10/14/1997	US5677176 Animal derived cell with antigenic protein introduced therein
10/14/1997	US5677171 Inhibit growth of sk-br-3 breast tumor cells
10/14/1997	US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation
10/14/1997	US5677149 Culturing under suitable conditions a host cell transformed or trasnfected with a replicable vector comprising specific nucleic acid sequence in a manner allowing expression of the polypeptide and recovering transformed polypeptide
10/14/1997	US5676946 Phospholipase C homolog
10/14/1997	US5676940 Method of reducing immunoglobulin E responses
10/14/1997	US5676929 Canister containing aerosol formulations containing P134a and particulate medicaments
10/14/1997	CA2130341C Compositions of clindamycin and benzoyl peroxide for acne treatment
10/12/1997	CA2202425A1 A novel anti-spasmodic and antiinflammatory composition and a process for the manufacture thereof
10/09/1997	WO1997037230A1 Tfiib transcription factor from candida albicans
10/09/1997	WO1997037043A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/09/1997	WO1997037037A1 Phosphatase modulator
10/09/1997	WO1997037026A1 Novel compounds
10/09/1997	WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use
10/09/1997	WO1997037015A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/09/1997	WO1997037005A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	WO1997037002A1 Promotion of regeneration of organized tissues
10/09/1997	WO1997036927A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	WO1997036925A1 Candida albicans tata-binding protein, nucleic acid and assays
10/09/1997	WO1997036874A1 Eprosartan dihydrate and a process for its production and formulation
10/09/1997	WO1997036869A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/09/1997	WO1997036609A2 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
10/09/1997	WO1997036608A1 CONTROL OF CANCER GROWTH THROUGH THE INTERACTION OF [MET5]-ENKEPHALIN AND THE ZETA (z) RECEPTOR
10/09/1997	WO1997036587A1 A method of treating cancer
10/09/1997	WO1997036581A1 Photopheresis treatment of leukocytes
10/09/1997	WO1997036576A1 Preparation method of emulsion for chemoembolization
10/09/1997	WO1997036574A1 Process and device for inhalation of particulate medicaments
10/09/1997	WO1997036495A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/09/1997	WO1997021820A3 A novel protein kinase required for ras signal transduction
10/09/1997	DE19613691A1 Arzneimittel für die Behandlung von Tumorerkrankungen Drugs for the treatment of tumor diseases
10/09/1997	CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	CA2250232A1 A method of treating cancer
10/09/1997	CA2250217A1 Process and device for inhalation of particulate medicaments
10/09/1997	CA2250129A1 Candida albicans tata-binding protein, nucleic acid and assays
10/09/1997	CA2250121A1 Tfiib transcription factor from candida albicans
10/09/1997	CA2249459A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	CA2249369A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/09/1997	CA2248729A1 Promotion of regeneration of organized tissues
10/09/1997	CA2247996A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/09/1997	CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997	EP0799619A2 Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and treatment of benign prostatic hyperplasia
10/08/1997	EP0799618A2 Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
10/08/1997	EP0799615A1 Liposome eye drops
10/08/1997	EP0799315A2 Telomerase protein component
10/08/1997	EP0799314A2 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
10/08/1997	EP0799311A1 Human chemokine beta-9
10/08/1997	EP0799174A1 Biocidal alcohols, their production and their use
10/08/1997	EP0799056A1 Use of a tachykinin antagonist and an opioid analgesic
10/08/1997	EP0799055A1 Selective and non-invasive visualization or treatment of vasculature
10/08/1997	EP0799054A1 Conjugate for treating inflammatory diseases
10/08/1997	EP0799051A2 Irrigation solution and method for inhibition of pain, inflammation and spasm
10/08/1997	EP0799045A1 New method of treatment
10/08/1997	EP0799042A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
10/08/1997	EP0799037A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/08/1997	EP0799023A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/08/1997	EP0799022A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
10/08/1997	EP0799020A1 Cosmetic and dermatological preparations with flavonoids
10/08/1997	CN1161647A Compositions and method for controlling smoking
10/07/1997	US5674912 Sunscreen-wound healing compositions and methods for preparing and using same
10/07/1997	US5674911 Administering therapeutic drug dispersed in polyoxyethylene-polyoxypropylene copolymer surfactant
10/07/1997	US5674903 Method of using citric acid for treating wrinkles
10/07/1997	US5674899 Method of using lactic acid for treating wrinkles
10/07/1997	US5674898 Methods and therapeutic compositions for treating cystic fibrosis

1 ... 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 ... 1151